Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES24 - Palliative Care Integration and QOL in Advanced Lung Cancer

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Palliative and Supportive Care
    • +

      Session Moderator

      15:11 - 15:23  |  Presenter: Charu Aggarwal

      • Abstract

      Loading...

    • +

      Session Moderator

      15:11 - 15:23  |  Presenter: Karin Dieckmann

      • Abstract

      Loading...

    • +

      ES24.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Charu Aggarwal

      • Abstract

      Loading...

    • +

      ES24.02 - Session Introduction

      14:46 - 14:47  |  Presenter: Karin Dieckmann

      • Abstract

      Loading...

    • +

      ES24.03 - Early Palliative Care in Advanced Non-small-Cell Lung Cancer

      14:47 - 14:59  |  Presenter: Jennifer Temel

      • Abstract

      Loading...

    • +

      ES24.04 - Treatment Decision-Making for Patients with Complicated Bone Metastases

      14:59 - 15:11  |  Presenter: Thanyanan Baisamut

      • Abstract

      Loading...

    • +

      ES24.05 - What Is the Role of Supporting Care to Improve Checkpoint Inhibitor Tolerance?

      15:11 - 15:23  |  Presenter: Mirjana Rajer

      • Abstract

      Loading...

    • +

      ES24.06 - The Management of Pain in Lung Cancer: Pharmacological Interventions

      15:23 - 15:35  |  Presenter: Marliese Alexander

      • Abstract

      Loading...

    • +

      ES24.07 - Live Q&A

      15:35 - 15:45

      • Abstract

      Loading...

  • +

    MA09 - Palliative Radiotherapy: The Changing Landscape with Immunotherapy and Targeted Therapies

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
    • +

      Session Moderator

      15:27 - 15:35  |  Presenter: Milada Zemanova

      • Abstract

      Loading...

    • +

      Session Moderator

      15:27 - 15:35  |  Presenter: David Ball

      • Abstract

      Loading...

    • +

      MA09.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Milada Zemanova

      • Abstract

      Loading...

    • +

      MA09.02 - Session Introduction

      14:46 - 14:47  |  Presenter: David Ball

      • Abstract

      Loading...

    • +

      MA09.03 - Response of Palliative Radiotherapy in Bone Metastases of Lung Cancer - Results of Prospective Longitudnal Study from India

      14:47 - 14:52  |  Presenter: Amiya Agrawal

      • Abstract

      Loading...

    • +

      MA09.04 - First-line PD-1 Inhibitors and Chemotherapy Combined with or without Radiotherapy in Advanced Non-small-cell Lung Cancer

      14:52 - 14:57  |  Presenter: Xiaorong Dong

      • Abstract

      Loading...

    • +

      MA09.05 - Increased PD-L1 Tracer Uptake in Recently-irradiated Lesions in NSCLC: Preliminary Results of a Phase 0 Trial (ImmunoPET) of a Novel PET Tracer

      14:57 - 15:02  |  Presenter: Michael Patrick MacManus

      • Abstract

      Loading...

    • +

      MA09.06 - Discussant

      15:02 - 15:12  |  Presenter: Kristin Higgins

      • Abstract

      Loading...

    • +

      MA09.07 - Understanding Outcomes of Patients with Metastatic Non-Small Cell Lung Carcinoma Undergoing Whole Brain vs Stereotactic Radiotherapy

      15:12 - 15:17  |  Presenter: Dhruv Abhi

      • Abstract

      Loading...

    • +

      MA09.08 - Radiotherapy Improves Outcomes to Immunotherapy in Patients with Stage III and IV NSCLC

      15:17 - 15:22  |  Presenter: Shuling Li

      • Abstract

      Loading...

    • +

      MA09.09 - Perilesional Edema and Size of Brain Metastases as Prognostic and Predictive Factors to Local Therapy in Advanced Non-small-Cell Lung Cancer

      15:22 - 15:27  |  Presenter: Oscar Arrieta

      • Abstract

      Loading...

    • +

      MA09.10 - Discussant

      15:27 - 15:27  |  Presenter: Ursula Nestle

      • Abstract

      Loading...

    • +

      MA09.11 - Live Q&A

      15:27 - 15:35

      • Abstract

      Loading...

  • +

    MA10 - Updates in Thymoma

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      Session Moderator

      15:22 - 15:27  |  Presenter: Noboru Yamamoto

      • Abstract

      Loading...

    • +

      Session Moderator

      15:22 - 15:27  |  Presenter: Paul J Van Houtte

      • Abstract

      Loading...

    • +

      MA10.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Noboru Yamamoto

      • Abstract

      Loading...

    • +

      MA10.02 - Session Introduction

      14:46 - 14:47  |  Presenter: Paul J Van Houtte

      • Abstract

      Loading...

    • +

      MA10.03 - Is Thoracoscopic Thymectomy Safe and Oncologically Sound in Large Thymic Tumors?

      14:47 - 14:52  |  Presenter: Karthik Venkataramani

      • Abstract

      Loading...

    • +

      MA10.04 - Long-term Follow-up Study of Thymic Epithelial Tumors. Report of the Updated Nation-wide Database in Japan

      14:52 - 14:57  |  Presenter: Meinoshin Okumura

      • Abstract

      Loading...

    • +

      MA10.05 - High Levels of CD47 Expression in Thymic Epithelial Tumors

      14:57 - 15:02  |  Presenter: Thomas Yang Sun

      • Abstract

      Loading...

    • +

      MA10.06 - Discussant

      15:02 - 15:12  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      Loading...

    • +

      MA10.07 - Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)

      15:12 - 15:17  |  Presenter: Claudia Proto

      • Abstract

      Loading...

    • +

      MA10.08 - Activated Pathways of Myastenia Gravis in Thymic Epithelial (TETs)

      15:17 - 15:22  |  Presenter: Jose Carlos Benítez

      • Abstract

      Loading...

    • +

      MA10.09 - Outcomes of Induction Therapy Followed by Surgical Resection for Advanced Thymic Tumor

      15:22 - 15:27  |  Presenter: Sumin Shin

      • Abstract

      Loading...

    • +

      MA10.10 - Discussant

      15:27 - 15:37  |  Presenter: Alessandra Curioni-Fontecedro

      • Abstract

      Loading...

    • +

      MA10.11 - Live Q&A

      15:37 - 15:45

      • Abstract

      Loading...

  • +

    OA09 - Precision Immunotherapy via Modulation of the Tumor Microenvironment

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Oral
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      14:46 - 14:47  |  Presenter: Kurt Alex Schalper

      • Abstract

      Loading...

    • +

      Session Moderator

      14:46 - 14:47  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      OA09.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Kurt Alex Schalper

      • Abstract

      Loading...

    • +

      OA09.02 - Session Introduction

      14:46 - 14:47  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      OA09.03 - Single Cell Analyses Reveal Effects of Immunosenescence Cells in Neoadjuvant Immunotherapy of Lung Squamous cell Carcinoma Patients

      14:47 - 14:57  |  Presenter: Tao Wang

      • Abstract

      Loading...

    • +

      OA09.04 - Spatial Mapping and Clinical Significance of the LAG-3/FGL1 Pathway in Non-small Cell Lung Cancer Using High-Dimensional Tissue Imaging

      14:57 - 15:07  |  Presenter: Shruti S. Desai

      • Abstract

      Loading...

    • +

      OA09.05 - Neoadjuvant IL-15-PDL1 Antibody Promotes T cell Memory and Decreases Metastatic Recurrence in Resectable NSCLC

      15:07 - 15:17  |  Presenter: Jonathan Villena-Vargas

      • Abstract

      Loading...

    • +

      OA09.06 - Vascular Leakage Promotes Immunosuppression and is Associated with Reduced Patient Survival in Non-Small Cell Lung Cancer

      15:17 - 15:27  |  Presenter: Emmanuel Nwadozi

      • Abstract

      Loading...

    • +

      OA09.07 - Discussant

      15:27 - 15:37  |  Presenter: Umberto Malapelle

      • Abstract

      Loading...

    • +

      OA09.08 - Live Q&A

      15:37 - 15:45

      • Abstract

      Loading...

  • +

    OA10 - Strategies to Integrate Smoking Cessation and Cancer Care

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Strauss 3
    • Not for CME Credit
    • Type: Oral
    • Track: Tobacco Control and Risk Reduction
    • +

      Session Moderator

      14:57 - 15:07  |  Presenter: Enrica Capelletto

      • Abstract

      Loading...

    • +

      Session Moderator

      14:57 - 15:07  |  Presenter: Manfred Neuberger

      • Abstract

      Loading...

    • +

      OA10.01 - Session Introduction

      14:45 - 14:46  |  Presenter: Enrica Capelletto

      • Abstract

      Loading...

    • +

      OA10.02 - Session Introduction

      14:46 - 14:47  |  Presenter: Manfred Neuberger

      • Abstract

      Loading...

    • +

      OA10.03 - A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting

      14:47 - 14:57  |  Presenter: Randi M. Williams

      • Abstract

      Loading...

    • +

      OA10.04 - Opt-out Outperforms Opt-in Smoking Cessation Treatment One-month Post Randomization

      14:57 - 15:07  |  Presenter: Babalola Faseru

      • Abstract

      Loading...

    • +

      OA10.05 - Integrating Smoking Cessation into LDCT Lung Cancer Screening. Results of the Ontario, Canada, Pilot

      15:07 - 15:17  |  Presenter: Bill Kenneth Evans

      • Abstract

      Loading...

    • +

      OA10.06 - An Unconventional Financial Incentive Based Feasibility Trial for Smoking Cessation

      15:17 - 15:27  |  Presenter: Gregory Earl Holt

      • Abstract

      Loading...

    • +

      OA10.07 - Discussant

      15:27 - 15:37  |  Presenter: Patrizia Froesch

      • Abstract

      Loading...

    • +

      OA10.08 - Live Q&A

      15:37 - 15:55

      • Abstract

      Loading...

  • +

    ES25 - Clinical Issues with Immunotherapy in Non-small Cell Lung Cancer

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      Session Moderator

      16:38 - 16:50  |  Presenter: Martin Reck

      • Abstract

      Loading...

    • +

      Session Moderator

      16:38 - 16:50  |  Presenter: Sanjay Popat

      • Abstract

      Loading...

    • +

      ES25.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Martin Reck

      • Abstract

      Loading...

    • +

      ES25.02 - Session Introduction

      16:01 - 16:02  |  Presenter: Sanjay Popat

      • Abstract

      Loading...

    • +

      ES25.03 - First-Line Choice in PD-L1 Positive Patients

      16:02 - 16:14  |  Presenter: Filiz Oezkan

      • Abstract

      Loading...

    • +

      ES25.04 - First-Line Choice in PD-L1 Negative Patients

      16:14 - 16:26  |  Presenter: Delvys Rodriguez-Abreu

      • Abstract

      Loading...

    • +

      ES25.05 - Second-Line Options in Immune-Pretreated Patients

      16:26 - 16:38  |  Presenter: Keunchil Park

      • Abstract

      Loading...

    • +

      ES25.06 - Immunotherapy in Oncogene-Addicted NSCLC

      16:38 - 16:50  |  Presenter: Francesco Passiglia

      • Abstract

      Loading...

    • +

      ES25.07 - Live Q&A

      16:50 - 17:00

      • Abstract

      Loading...

  • +

    ES26 - Thymoma

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      Session Moderator

      16:50 - 17:00  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      Loading...

    • +

      Session Moderator

      16:50 - 17:00  |  Presenter: David Waller

      • Abstract

      Loading...

    • +

      ES26.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      Loading...

    • +

      ES26.02 - Session Introduction

      16:01 - 16:02  |  Presenter: David Waller

      • Abstract

      Loading...

    • +

      ES26.03 - Pathological Staging of Thymic Epithelial Tumors

      16:02 - 16:14  |  Presenter: Anja C Roden

      • Abstract

      Loading...

    • +

      ES26.04 - How to Implement Surgery in the Multimodality Therapy of Thymic Epithelial Tumors

      16:14 - 16:26  |  Presenter: Enrico Ruffini

      • Abstract

      Loading...

    • +

      ES26.05 - Risks and Options of IO Therapy in Thymic Epithelial Tumors

      16:26 - 16:38  |  Presenter: Chen Zhao

      • Abstract

      Loading...

    • +

      ES26.06 - Indications for Radiation Therapy

      16:38 - 16:50  |  Presenter: Anna Wrona

      • Abstract

      Loading...

    • +

      ES26.07 - Live Q&A

      16:50 - 17:00

      • Abstract

      Loading...

  • +

    ES27 - Joint Global Lung Cancer Coalition and International Association for the Study of Lung Cancer Session - Breaking Down Roadblocks to Lung Cancer Care in 2022

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Patient Advocacy
    • +

      Session Moderator

      16:00 - 16:00  |  Presenter: Carolyn Aldige

      • Abstract

      Loading...

    • +

      Session Moderator

      16:00 - 16:00  |  Presenter: David Baldwin

      • Abstract

      Loading...

    • +

      Session Moderator

      16:52 - 17:00  |  Presenter: Ugo Pastorino

      • Abstract

      Loading...

    • +

      ES27.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Carolyn Aldige

      • Abstract

      Loading...

    • +

      ES27.02 - Session Introduction

      16:01 - 16:02  |  Presenter: Ugo Pastorino

      • Abstract

      Loading...

    • +

      ES27.02 - Session Introduction

      16:01 - 16:02  |  Presenter: David Baldwin

      • Abstract

      Loading...

    • +

      ES27.03 - Mitigating the Effects of COVID - How Does Lung Cancer Recover?

      16:02 - 16:12  |  Presenter: David Baldwin

      • Abstract

      Loading...

    • +

      ES27.04 - Lung Cancer Screening - From Pilots to Programs and the Effects of Patient Advocacy

      16:12 - 16:22  |  Presenter: Shani Shilo

      • Abstract

      Loading...

    • +

      ES27.05 - Lung Cancer Screening - From Pilots to Programs

      16:22 - 16:32  |  Presenter: Matthew Peters

      • Abstract

      Loading...

    • +

      ES27.06 - Lung Cancer Patient Experience - The Impact of COVID

      16:32 - 16:42  |  Presenter: Merel Hennink

      • Abstract

      Loading...

    • +

      ES27.07 - Optimising Telehealth for the Lung Cancer Patient

      16:42 - 16:52  |  Presenter: Lauren Pretorius

      • Abstract

      Loading...

    • +

      ES27.08 - Live Q&A

      16:52 - 17:00

      • Abstract

      Loading...

  • +

    MA11 - Optimization of Technologies for Lung Cancer Screening: Population Selection and Nodule Handling

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Lehar 1
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Early Detection and Screening
    • +

      Session Moderator

      16:52 - 17:00  |  Presenter: Anna Kerpel-Fronius

      • Abstract

      Loading...

    • +

      Session Moderator

      16:52 - 17:00  |  Presenter: Annemiek Snoeckx

      • Abstract

      Loading...

    • +

      MA11.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Anna Kerpel-Fronius

      • Abstract

      Loading...

    • +

      MA11.02 - Session Introduction

      16:01 - 16:02  |  Presenter: Annemiek Snoeckx

      • Abstract

      Loading...

    • +

      MA11.03 - Updated Cost-Effectiveness Analysis of Lung Cancer Screening for Australia, Capturing Differences in the Impact of NELSON and NLST Outcomes

      16:02 - 16:07  |  Presenter: Preston Ngo

      • Abstract

      Loading...

    • +

      MA11.04 - Genetic Variants of HUNT Lung Cancer Model Improve Lung Cancer Risk Assessment Over Clinical Models

      16:07 - 16:12  |  Presenter: Olav Toai Duc Nguyen

      • Abstract

      Loading...

    • +

      MA11.05 - The Blood Proteome of Imminent Lung Cancer

      16:12 - 16:17  |  Presenter: Hana Zahed

      • Abstract

      Loading...

    • +

      MA11.06 - Discussant

      16:17 - 16:27  |  Presenter: Carole Ridge

      • Abstract

      Loading...

    • +

      MA11.07 - The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World

      16:27 - 16:32  |  Presenter: Stephen Lam

      • Abstract

      Loading...

    • +

      MA11.08 - Value of Computer Aided Diagnosis on Radiologists’ Workflow and Recommendation for Reporting Lung Cancer Screening LDCT

      16:32 - 16:37  |  Presenter: Ren Yuan

      • Abstract

      Loading...

    • +

      MA11.09 - Artificial Intelligence in Lung Cancer Screening: Accuracy and Predictive Value

      16:37 - 16:42  |  Presenter: Ricardo Sales Santos

      • Abstract

      Loading...

    • +

      MA11.10 - Discussant

      16:42 - 16:52  |  Presenter: Arjun Nair

      • Abstract

      Loading...

    • +

      MA11.11 - Live Q&A

      16:52 - 17:00

      • Abstract

      Loading...

  • +

    OA11 - Optimal Patient Selection for Local Therapy in Stage IV NSCLC

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
    • +

      Session Moderator

      16:12 - 16:22  |  Presenter: Pablo Munoz-Schuffenegger

      • Abstract

      Loading...

    • +

      Session Moderator

      16:12 - 16:22  |  Presenter: Mariana Brandao

      • Abstract

      Loading...

    • +

      OA11.01 - Session Introduction

      16:00 - 16:01  |  Presenter: Pablo Munoz-Schuffenegger

      • Abstract

      Loading...

    • +

      OA11.02 - Session Introduction

      16:01 - 16:02  |  Presenter: Mariana Brandao

      • Abstract

      Loading...

    • +

      OA11.03 - Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Non-Small Cell Lung Cancer: A Marker of Better Prognosis

      16:02 - 16:12  |  Presenter: Peter Lee Zhan

      • Abstract

      Loading...

    • +

      OA11.04 - The Factors Associated With Reduced Risk of Progression in Patients With Oligometastatic NSCLC Treated With Local Ablative Radiotherapy

      16:12 - 16:22  |  Presenter: Gowoon Yang

      • Abstract

      Loading...

    • +

      OA11.05 - Treatment Strategies Based on Different Oligoprogressive Patterns after Immunotherapy Resistance in Advanced NSCLC

      16:22 - 16:32  |  Presenter: Shun Lu

      • Abstract

      Loading...

    • +

      OA11.06 - Sequencing of ctDNA Revealed Radiotherapeutic Efficacy and Prognosis in Non-small Cell Lung Cancer Patients with Brain Metastasis

      16:32 - 16:42  |  Presenter: Xiaorong Dong

      • Abstract

      Loading...

    • +

      OA11.07 - Discussant

      16:42 - 16:52  |  Presenter: Digambar Behera

      • Abstract

      Loading...

    • +

      OA11.08 - Live Q&A

      16:52 - 17:00

      • Abstract

      Loading...